Literature DB >> 18498191

Further investigation of lipid-substituted poly(L-Lysine) polymers for transfection of human skin fibroblasts.

Meysam Abbasi1, Hasan Uludag, Vanessa Incani, Charlie Yu Ming Hsu, Andrea Jeffery.   

Abstract

Enabling gene expression in skin fibroblasts using safe, nonviral gene delivery has the potential to stimulate wound healing and aid in skin tissue engineering efforts. In this study, several lipid-substituted poly(L-Lysines) (PLL) were investigated for their ability to deliver a plasmid DNA (pEGFP) to human skin fibroblasts. While native and lipid-substituted PLLs showed complete complexation with pEGFP, polymers with higher lipid substitution were more resilient to dissociation after heparin treatment. All polymers showed good protection of pEGFP against DNase I and DNase II digestion in vitro. DNA delivery studies using fluorescently labeled pEGFP showed that native PLL lacked the ability to deliver pEGFP into cells, whereas most of the lipid-substituted PLLs gave efficient pEGFP delivery into the cells. Extent of lipid substitution was an important factor in DNA delivery efficiency. The intracellular pEGFP was intact after delivery with lipid-substituted polymers up to 7 days. An RT-PCR methodology indicated successful transcription of the reporter GFP gene, which was not the case when the cells were transfected with a blank plasmid containing no functional GFP gene. Further studies with flow cytometry showed that successful protein expression was obtained with PLLs substituted with myristic and stearic acid, the latter displaying a relatively lower toxicity. We conclude that substituting lipids on PLL results in effective gene carriers and the extent of substitution, rather than the individual lipid, appeared to be critical for effective plasmid delivery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18498191     DOI: 10.1021/bm800132n

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  7 in total

1.  siRNA-mediated down-regulation of P-glycoprotein in a Xenograft tumor model in NOD-SCID mice.

Authors:  Meysam Abbasi; Hamidreza Montazeri Aliabadi; Elaine H Moase; Afsaneh Lavasanifar; Kamaljit Kaur; Raymond Lai; Charles Doillon; Hasan Uludağ
Journal:  Pharm Res       Date:  2011-06-03       Impact factor: 4.200

Review 2.  Micelle-like nanoparticles as carriers for DNA and siRNA.

Authors:  Gemma Navarro; Jiayi Pan; Vladimir P Torchilin
Journal:  Mol Pharm       Date:  2015-01-12       Impact factor: 4.939

3.  Polycationic nanoparticles: (1) synthesis of a polylysine-MION conjugate and its application in labeling fibroblasts.

Authors:  Ernest V Groman; Meiheng Yang; Christopher P Reinhardt; James S Weinberg; Dennis E Vaccaro
Journal:  J Cardiovasc Transl Res       Date:  2009-01-14       Impact factor: 4.132

4.  Nonviral delivery of basic fibroblast growth factor gene to bone marrow stromal cells.

Authors:  Başak Açan Clements; Charlie Y M Hsu; Cezary Kucharski; Xiaoyue Lin; Laura Rose; Hasan Uludağ
Journal:  Clin Orthop Relat Res       Date:  2009-06-04       Impact factor: 4.176

5.  Engineering biodegradable and multifunctional peptide-based polymers for gene delivery.

Authors:  Julie Shi; Joan G Schellinger; Suzie H Pun
Journal:  J Biol Eng       Date:  2013-10-24       Impact factor: 4.355

6.  BSA Nanoparticles for siRNA Delivery: Coating Effects on Nanoparticle Properties, Plasma Protein Adsorption, and In Vitro siRNA Delivery.

Authors:  Haran Yogasundaram; Markian Stephan Bahniuk; Harsh-Deep Singh; Hamidreza Montezari Aliabadi; Hasan Uludağ; Larry David Unsworth
Journal:  Int J Biomater       Date:  2012-08-07

Review 7.  Polylysine for skin regeneration: A review of recent advances and future perspectives.

Authors:  Payam Zarrintaj; Sadegh Ghorbani; Mahmood Barani; Narendra Pal Singh Chauhan; Mohsen Khodadadi Yazdi; Mohammad Reza Saeb; Joshua D Ramsey; Michael R Hamblin; Masoud Mozafari; Ebrahim Mostafavi
Journal:  Bioeng Transl Med       Date:  2021-11-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.